01 20Janssen Inc.
01 72310926
02 72310950
03 62358062
01 20Galantamine Hydrobromide
01 18Extended Release Capsule
02 2Oral Solution
01 62017-06-06
02 32019-12-20
03 112020-06-27
Patent Expiration Date : 2020-06-27
Date Granted : 2005-11-08
Brand Name : REMINYL
Patent Number : 2310950
Filing Date : 2000-06-27
Strength per Unit : 4 mg/ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2005-11-08
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Brand Name : REMINYL
Patent Number : 2310926
Filing Date : 2000-06-27
Strength per Unit : 4 mg/ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Brand Name : REMINYL ER
Patent Number : 2310926
Filing Date : 2000-06-27
Strength per Unit : 8 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Patent Expiration Date : 2019-12-20
Date Granted : 2006-12-19
Brand Name : REMINYL ER
Patent Number : 2358062
Filing Date : 1999-12-20
Strength per Unit : 8 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-20
Date Granted : 2006-12-19
Patent Expiration Date : 2020-06-27
Date Granted : 2005-11-08
Brand Name : REMINYL ER
Patent Number : 2310950
Filing Date : 2000-06-27
Strength per Unit : 8 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2005-11-08
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Brand Name : REMINYL ER
Patent Number : 2310926
Filing Date : 2000-06-27
Strength per Unit : 16 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Patent Expiration Date : 2019-12-20
Date Granted : 2006-12-19
Brand Name : REMINYL ER
Patent Number : 2358062
Filing Date : 1999-12-20
Strength per Unit : 16 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-20
Date Granted : 2006-12-19
Patent Expiration Date : 2020-06-27
Date Granted : 2005-11-08
Brand Name : REMINYL ER
Patent Number : 2310950
Filing Date : 2000-06-27
Strength per Unit : 16 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2005-11-08
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Brand Name : REMINYL ER
Patent Number : 2310926
Filing Date : 2000-06-27
Strength per Unit : 24 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-27
Date Granted : 2002-10-15
Patent Expiration Date : 2019-12-20
Date Granted : 2006-12-19
Brand Name : REMINYL ER
Patent Number : 2358062
Filing Date : 1999-12-20
Strength per Unit : 24 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-20
Date Granted : 2006-12-19
